Send Your Enquiry
About Dr. Sudha Sinha
- Dr. Sudha Sinha is an oncologist with over 15 of experience. She is also a renowned hematologist.
- She has special interest in women related cancers such as Breast Cancer and Gestational trophoblastic diseases.
- She worked on the expression and purification of erythrocyte macrophage protein and development of Anti-EMP antibodies.
- She worked on the development of cystein protease inhibitors as anti-malarial Drugs, and on the investigation of molecular mechanisms by which erythroblast-macrophage interactions promote erythroid maturation.
- She established the department of medical oncology, 60-bed adult leukemia program and 80 pediatric oncology programs.
- Dr. Sudha Sinha is a member of European Society of Medical Oncology and Indian Medical Association.
- After completing her MBBS from Gandhi Medical College, University of Health Sciences; Hyderabad (1996), she was Intern in Internal medicine at St. Barnabas medical center Livingston, NJ. USA from 1998 -1999. She was also Resident in internal medicine at Barnabas Medical Center Livingston, NJ. USA (1999- 2001).
- Dr. Sinha held the post of Assistant Professor at MNJ Institute of oncology and regional cancer center, Hyderabad She also started The ICMR ( Indian Council of Medical Research) funded hospital based national cancer registry program.
Location
MBBS, Gandhi Medical College, University of Health Sciences, Hyderabad(1996)- Fellowship, Fellowship, Caritas St. Elizabeth’s Medical Center Tufts University School of Medicine Boston, MA. USA(2005)
- Fellowship, Fellowship, Caritas St. Elizabeth’s Medical Center, Tufts University School of Medicine, Boston, MA. USA(2005)
• Member of European Society of Medical Oncology
• Member of Indian Medical Association.
- Senior Consultant, American Oncology Institute, Hyderabad(2020)
- Senior Consultant, Continental Hospitals, Hyderabad(2017)
- Assistant Professor, MNJ Institute of Oncology and Regional Cancer Center, Hyderabad(2017)
Papers Published
- Cingeetham A, Vuree S, Dunna NR, Gorre M, Nanchari SR, Edathara PM, Meka P, Annamaneni S, Digumarthi R, Sinha S, Satti V. Tumour Biol. 2015 May 10. Influence Of BCL2-938C >A And BAX-248G>A Promoter Polymorphisms In the Development of AML: Case-control study from south India
+ Read More- Show Less
- Cingeetham A1, Vuree S, Jiwatani S, Kagita S, Dunna NR, Meka PB, Gorre M, Annamaneni S, Digumarti R, Sinha S, Satti V. Asian Pac J Cancer Prev. 2015;16(7):2707-12. Role of The MDM2 Promoter Polymorphism (-309T>G) In Acute Myeloid Leukemia Development
- Digumarti R, Sinha S, Nirni SS, Patil SG, Pedapenki RM. Indian J Cancer. 2014 51(2):180-3. Efficacy of Rasburicase (Recombinant Urate Oxidase) in the prevention and treatment of Malignancy-Associated Hyperuricemia: An Indian Experience.
- Chiranjeevi P, Spurthi KM, Rani NS, Kumar GR, Aiyengar TM, Saraswati M, Srilatha G, Kumar GK, Sinha S, Kumari CS, Reddy BN, Vishnupriya S, Rani HS. Tumour Biol. 2013 Dec 20. [Epub Ahead of Print]. Gelatinase B (- 1562C/T) Polymorphism In Tumor Progression And Invasion of Breast Cancer.
- Attili SV, Ananda B, Mandapal T, Anjaneyulu V, Sinha S, Reddy OC. Gastrointest Cancer Res. 2011 Sep;4(5-6):173-7.Factors influencing progression- free survival in gastrointestinal stromal tumors with special reference to pathologic features, cytogenetics and radiologic response.
- Suresh AV, Varma PP, Sinha S, Deepika S, Raman R, Srinivasan M, Mandapal T, Reddy CO, Anand BB. J Cancer Res Ther. 2010 Oct- Dec;6(4):448-51.Risk-Scoring System For Predicting Mucositis In Patients of Head And Neck Cancer Receiving Concurrent Chemoradiotherapy .
- Chirivella S, Rajappa S, Sinha S, Eden T, Barr RD. Indian J Pediatr. 2009 Dec;76(12):1231-Health-Related Quality of Life Among Children With Cancer In Hyderabad, India.
- Bala S, Kumar A, Soni S, Sinha S, Hanspal M.Biochem Biophys Res Commun. 2006 Apr 21; 342(4):1040-8. Emp Is A Component of The Nuclear Matrix of Mammalian Cells And Undergoes Dynamic Rearrangements During Cell Division.
- Sinha S, Poh KK, Sodano D, Flanagan J, Ouilette C, Kearney M, Heyd L, Wollins J, Losordo D, Weinstein R.J Clin Apher. 2006 Jul;21(2):116-20.Safety And Efficacy of Peripheral Blood Progenitor Cell Mobilization And Collection In Patients With Advanced Coronary Heart Disease.
Send Your Enquiry
Fill in your details and our medical experts will contact you within 24 hours.
Want to consult the doctor?
Don't Ignore Your Health!
Other Top Medical Oncologist In Hyderabad
Chat
Dr. A. V. S. Suresh
5.0 (32 Ratings)
Medical Oncologist
Continental Hospitals, Hyderabad · Hyderabad
20+ years of experience
FAQ's About Dr. Sudha Sinha
Where does Dr. Sudha Sinha practice?
Dr. Sudha Sinha practices at Care Hospitals, HITEC City
What is the specialty of Dr. Sudha Sinha?
Dr. Sudha Sinha specialty is Medical Oncologist
What is the experience of Dr. Sudha Sinha?
Dr. Sudha Sinha is Medical Oncologist with 21 years of experience.
Chat